Definiens, Inc. - Definiens AG
We improve patient lives by unlocking the tissue phenome
In oncology, therapeutic strategies have shifted from a direct assault on cancer cells to recruiting the immune system for that purpose.
Our mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer-relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies.
Our vision is to create unique patient profiles for an individualized standard of care, where patients experience fewer side effects and live longer.